With unprecedented sensitivity, Carnegie Mellon University’s Mark Bier has characterized large viral particles and bulky von Willebrand factors using a novel mass spectrometer. These exciting results may lead to new biological discoveries and represent a step closer to rapid disease diagnosis using mass spectrometry.

Researchers from the University of Minnesota Medical School and Brain Sciences Center at the Minneapolis VA Medical Center have identified a noninvasive and painless way to diagnose complex brain diseases. And it’s as simple as staring at a point of light. The research offers promise for a less-stressful, painless, and objective diagnosis for brain diseases, as well as a way to measure the effectiveness of different treatments for these diseases.

Purdue University researchers worked with the Indiana University School of Medicine to establish a technique that provides a new approach for detecting a number of genetic disorders found in infants and young children.